Sai Parenterals

About the Company

Sai Parenteral’s Limited is a diversified pharmaceutical formulations company incorporated in January 2001. It was originally established as a private limited company and was converted into a public limited company in January 2022. Anil Kumar Karusala, Vijitha Gorrepati and Karusala Aruna promote the Company. The Company operates across branded generic formulations and contract development and manufacturing (CDMO) services. Its product portfolio spans multiple therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, antibiotics, gastroenterology, respiratory care, dermatology, and vitamins and supplements. Offerings cover a wide range of dosage forms such as injectables, tablets, capsules, liquid orals and ointments.

Strengths

• Diversified pharma portfolio across branded generics and CDMO services
• Strong capabilities in sterile injectable manufacturing
• Presence across multiple therapeutic areas and dosage forms
• Promoter-led management with a long operating track record
• Multiple manufacturing facilities supported by in-house R&D

Risks

• High revenue dependence on injectable formulations
• Manufacturing facilities are concentrated in limited geographies
• Exposure to stringent regulatory inspections and compliance risks
• Dependence on third-party suppliers for key raw materials
• Customer concentration may affect revenue stability